title: Mometasone furoate versus betamethasone vale-rate in the treatment of allergic contact dermatitis.
authors.forename: M
authors.initials: M
authors.lastname: Grandolfo
authors.forename: G A
authors.initials: GA
authors.lastname: Vena
authors.forename: G
authors.initials: G
authors.lastname: Angelini
authors.forename: B
authors.initials: B
authors.lastname: Bianchi
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000368:Aged; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D008875:Middle Aged; D000068656:Mometasone Furoate; D011244:Pregnadienediols / Q000008:administration & dosage / Q000627:therapeutic use*; D016037:Single-Blind Method; D014945:Wound Healing
chemical_list: D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011244:Pregnadienediols; D000068656:Mometasone Furoate; D001624:Betamethasone Valerate